Efficacy of risperidone consta for improving ability to benefit from skills training in schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Antipsychotics; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2009 Trial phase changed from II to III as reported by ClinicalTrials.gov.
- 01 Sep 2006 New trial record.